2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Blood Plasma Derivatives Market?

The rise in immunodeficiency disorders is anticipated to fuel the expansion of the blood plasma derivatives market. These disorders, which impair the immune system either fully or partially, necessitate the use of blood plasma derivatives in treatment. Plasma, a mixture of proteins and salts with over 100 diverse proteins, notably makes use of immunoglobulins to manage primary immunodeficiencies. Lack of proper nutrition or malnutrition results in a deficiency of macro and micronutrients, potentially leading to immunodeficiency. For example, as reported by the Allergy, Asthma & Clinical Immunology in March 2022, the most frequently diagnosed condition was Common Variable Immunodeficiency (CVID), which impacted 16.6% of individuals in the US, 12.9% internationally, and 13.9% globally. Consequently, the escalating instances of immune deficiency ailments are propelling the growth of the blood plasma derivatives market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

#What is the Growth Potential of the Blood Plasma Derivatives Market, and How Will It Perform by 2034?

The market size of blood plasma derivatives has experienced substantial growth over the past few years. The market is projected to increase from $51.81 billion in 2024 to $56.24 billion in 2025, pacing at a Compound Annual Growth Rate (CAGR) of 8.6%. Several factors have contributed to this rise in the historical period, including a higher occurrence of hemophilia and bleeding disorders, a surge in the elderly population, improved awareness and diagnostic procedures, an increment in surgical procedures, and worldwide blood transfusion services.

Robust expansion in the blood plasma derivatives market is anticipated in the coming years, with a projected value of $80.42 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. The forecasted increase can be linked to the advent of treatments for rare diseases, rise in chronic illness, escalating healthcare spending, patient-focused treatment methods, and a growing healthcare infrastructure. The main trends for the projected period incorporate advancements in fractionation technologies, patient-focused strategies, collaborations and partnerships, extended applications in neurology, and technological progress in plasma fractionation.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

What New Market Trends Are Reshaping theBlood Plasma Derivatives Market and Its Opportunities?

Leading businesses in the blood plasma derivatives market are resorting to strategic collaborations in order to gain an upper hand in the market. Such partnerships ensure a reliable and constant supply of essential plasma-derived medicines for patients in need, addressing the growing demand for immunoglobulins not only in France but also globally. For example, In January 2022, an alliance was formed between Kedrion S.p.A., an Italian biopharmaceutical company known for the development, production, and distribution of plasma-derived therapies, and LFB, a UK-based pharmaceutical firm specialized in biological medicinal products. Kedrion plans to use the LFB plasma collected in France by the Etablissement Français du Sang (EFS) for the production of immunoglobulins in Hungary. The current immunoglobulins supply, designated for hospitals nationwide under the guidance of French health authorities, will be supplemented with these imports from LFB in France.

Who Are the Leading Market Players Fueling Growth in the Blood Plasma Derivatives Market Trend?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

How is the Global Blood Plasma Derivatives Market Segemented?

The blood plasma derivatives market covered in this report is segmented –

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Which Geographics are Influencing the Growth of the Blood Plasma Derivatives Market?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Blood Plasma Derivatives Maret 2025, By The Business Research Company:

Electrolyte Mixes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrolyte-mixes-global-market-report

Blood Group Typing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

Hemostasis Analyzers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: